Yesterday Eli Lilly signed a strategic partnership with Radionetics Oncology, which not only provides the pharma with a pipeline of promising cancer radiotherapeutics but also gives it the exclusive right to buy the San Diego biotech down the line.
The U.S. government has awarded $176 million to Moderna to advance development of its bird flu vaccine, the company said on Tuesday, as concerns rise over a multi-state outbreak of H5N1 virus in dairy cows and infections of three dairy workers since March.
Yesterday Cassava Sciences disclosed that two of its senior employees are under investigation by federal agencies in connection with alleged scientific misconduct in its Alzheimer’s disease studies.
The Federal Trade Commission has opened an investigation into Teva Pharmaceuticals after the company allegedly ignored directives to withdraw or amend contentious patent listings on the FDA’s Orange Book.
Aurigene will provide cell therapy discovery services to Edity to support the latter’s clinical development.
Colleen Carter will lead the rapidly growing Life Sciences division, which covers pharmaceutical, biotech, medical device, diagnostics, medtech, and digital health industries. Adam Pawluk, previously JPA’s Chief Client Officer, will now oversee JPA Labs, including creative, digital, earned media, serious games and research solutions.